Regarding to breast tumor intrinsic (molecular) classification, 55 cases (60%) had tumors classified as the luminal A subtype, whereas 37 (40%) patients had non-luminal A tumors, including luminal B, non-luminal HER2+, and triple negative. This evidence concerns the gene ERBB2 and breast neoplasm.